Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Merskey H, Bogduk N. Classification of chronic pain. 2nd ed. Seattle: IASP Press; 1994.
de Leeuw R, Klasser GD. In: de Leeuw R, Klasser GD, editors. Orofacial pain: guidelines for assessment, diagnosis and management. Hanover Park, IL: Quintessence; 2013. p. 127–186.
Kopp S. Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain. 2001;15(1):9–28.
Bouloux GF. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg. 2009;67(11):2497–504.
Chang H, Israel H. Analysis of inflammatory mediators in temporomandibular joint synovial fluid lavage samples of symptomatic patients and asymptomatic controls. J Oral Maxillofac Surg. 2005;63(6):761–5.
Sarlani E, Greenspan JD. Why look in the brain for answers to temporomandibular disorder pain? Cells Tissues Organs. 2005;180(1):69–75.
Clauw DJ, Arnold LM, McCarberg BH. The science of fibromyalgia. Mayo Clin Proc. 2011;86(9):907–11.
John MT, Miglioretti DL, LeResche L, Von Korff M, Critchlow CW. Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain. 2003;102(3):257–63.
Graff-Radford SB. Facial pain, cervical pain, and headache. Continuum (Minneap Minn). 2012;18(4):869–82.
Couppe C, Torelli P, Fuglsang-Frederiksen A, Andersen KV, Jensen R. Myofascial trigger points are very prevalent in patients with chronic tension-type headache: a double-blinded controlled study. Clin J Pain. 2007;23(1):23–7.
Jaeger B. Myofascial referred pain patterns: the role of trigger points. CDA J. 1985;13(3):27–32.
Lund JP, Donga R, Widmer CG, Stohler CS. The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol. 1991;69(5):683–94.
Tal M. Representation of some masticatory muscles in the trigeminal motor nucleus of the guinea pig: horseradish peroxidase study. Exp Neurol. 1980;70(3):726–30.
Sharav Y, Tal M. Masseter inhibitory periods and sensations evoked by electrical tooth-pulp stimulation in subjects under hypnotic anesthesia. Brain Res. 1989;479(2):247–54.
Benoliel R, Sharav Y. Craniofacial pain of myofascial origin: temporomandibular pain & tension-type headache. Compend Contin Educ Dent. 1998;19(7):701–704, 706, 708–710 passim; quiz 722.
Benoliel R, Svensson P, Heir GM, et al. Persistent orofacial muscle pain. Oral Dis. 2011;17(Suppl 1):23–41.
Benoliel R, Eliav E, Elishoov H, Sharav Y. Diagnosis and treatment of persistent pain after trauma to the head and neck. J Oral Maxillofac Surg. 1994;52(11):1138–1147; discussion 1147–1138.
Benoliel R, Birenboim R, Regev E, Eliav E. Neurosensory changes in the infraorbital nerve following zygomatic fractures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):657–65.
Nixdorf DR, Moana-Filho EJ, Law AS, McGuire LA, Hodges JS, John MT. Frequency of nonodontogenic pain after endodontic therapy: a systematic review and meta-analysis. J endod. 2010;36(9):1494–8.
Klasser GD, Kugelmann AM, Villines D, Johnson BR. The prevalence of persistent pain after nonsurgical root canal treatment. Quintessence Int. 2011;42(3):259–69.
Eliav E, Tal M, Benoliel R. Experimental malignancy in the rat induces early hypersensitivity indicative of neuritis. Pain. 2004;110(3):727–37.
Jaaskelainen SK, Peltola JK. Clinical application of the blink reflex with stimulation of the mental nerve in lesions of the inferior alveolar nerve. Neurology. 1994;44(12):2356–61.
Jaaskelainen SK, Teerijoki-Oksa T, Forssell H. Neurophysiologic and quantitative sensory testing in the diagnosis of trigeminal neuropathy and neuropathic pain. Pain. 2005;117(3):349–57.
Eliav E, Gracely RH. Sensory changes in the territory of the lingual and inferior alveolar nerves following lower third molar extraction. Pain. 1998;77(2):191–9.
Kalladka M, Proter N, Benoliel R, Czerninski R, Eliav E. Mental nerve neuropathy: patient characteristics and neurosensory changes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(3):364–70.
Svensson P, Baad-Hansen L, Pigg M, et al. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions—a taskforce report. J Oral Rehabil. 2011;38(5):366–94.
Fried K, Bongenhielm U, Boissonade FM, Robinson PP. Nerve injury-induced pain in the trigeminal system. Neuroscientist. 2001;7(2):155–65.
Benoliel R, Kahn J, Eliav E. Peripheral painful traumatic trigeminal neuropathies. Oral Dis. 2012;18(4):317–32.
Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol. 2009;194:3–30.
Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10(1):23–36.
Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev. 2002;82(4):981–1011.
Olesen J, Steiner T. The International classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry. 2004;75(6):808–11.
Lipton RB, Bigal ME, Steiner TJ, Silberstein SD, Olesen J. Classification of primary headaches. Neurology. 2004;63(3):427–35.
Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol. 2012;8(2):89–99.
Longoni M, Ferrarese C. Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci. 2006;27(Suppl 2):S107–10.
Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44(1):53–64.
Malick A, Burstein R. Peripheral and central sensitization during migraine. Funct Neurol. 2000;15(Suppl 3):28–35.
Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001;89(2–3):107–10.
Eliav E, Benoliel R. Chronic orofacial pain. Top Clin Nutr. 2005;20(3):219–28.
Hussain A, Stiles MA, Oshinsky ML. Pain remapping in migraine: a novel characteristic following trigeminal nerve injury. Headache. 2010;50(4):669–71.
Gaul C, Sandor PS, Galli U, Palla S, Ettlin DA. Orofacial migraine. Cephalalgia. 2007;27(8):950–2.
Dodick DW. Migraine with isolated facial pain: a diagnostic challenge. Cephalalgia. 2007;27(11):1199–200.
Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascular-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(5):506–12.
Benoliel R, Sharav Y, Eliav E. Neurovascular orofacial pain. J Am Dent Assoc. 2010;141(9):1094–6.
Eliav E, Benoliel R. Chronic orofacial pain. Top Clin Nutr. 2005;20(5):219–28.
Ekberg EC, Vallon D, Nilner M. Occlusal appliance therapy in patients with temporomandibular disorders. A double-blind controlled study in a short-term perspective. Acta Odontol Scand. 1998;56(2):122–8.
Forssell H, Kalso E, Koskela P, Vehmanen R, Puukka P, Alanen P. Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials. Pain. 1999;83(3):549–60.
Nitzan DW, Kreiner B, Zeltser R. TMJ lubrication system: its effect on the joint function, dysfunction, and treatment approach. Compend Contin Educ Dent. 2004;25(6):437–438, 440, 443–434 passim; quiz 449, 471.
Nitzan DW, Mahler Y, Simkin A. Intra-articular pressure measurements in patients with suddenly developing, severely limited mouth opening. J Oral Maxillofac Surg. 1992;50(10):1038–1042; discussion 1043.
Forssell H, Kalso E. Application of principles of evidence-based medicine to occlusal treatment for temporomandibular disorders: are there lessons to be learned? J Orofac Pain. 2004;18(1):9–22; discussion 23–32.
Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia. 2000;20(6):603–10.
Plesh O, Curtis D, Levine J, McCall WD Jr. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil. 2000;27(10):834–41.
Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain. 2002;16(1):64–70.
Harkins S, Linford J, Cohen J, Kramer T, Cueva L. Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandib Disord. 1991;5(3):179–86.
Clark G, Sahai-Srivaastava S. Skeletal muscle relaxants and antispasticity drugs for orofacial pain disorders. In: Clark G, Dionne R, editors. Orofacial Pain: a guide to medications and management. Oxford: Wiley-Blackwell; 2012. p. 115–28.
Graff-Radford SB. Facial pain. Neurologist. 2009;15(4):171–7.
Benoliel R, Sharav Y, Tal M, Eliav E. Management of chronic orofacial pain: today and tomorrow. Compend Contin Educ Dent. 2003;24(12):909–920, 922–904, 926–908 passim; quiz 932.
Katz J, Clarke H, Seltzer Z. Review article: Preventive analgesia: quo vadimus? Anesth Analg. 2011;113(5):1242–53.
Eliav E, Max MBM. Management of neuropathic pain. In: Sessle B, Lavigne GJ, Lund JP, Dubner R, editors. Orofacial pain: from basic science to clinical management. 2nd ed. Hanover Park: Quintessence; 2005. p. 195–202.
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289–305.
Dworkin RH, O’Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3–14.
Heir GM, Haddox JD, Crandall J, et al. Position paper: appropriate use of pharmacotherapeutic agents by the orofacial pain dentist. J Orofac Pain. 2011;25(4):381–90.
Anand KS, Dhikav V, Prasad A. Shewtengna. Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia. J Indian Med Assoc. 2011;109(4):264–6.
Skljarevski V, Zhang S, Iyengar S, et al. Efficacy of duloxetine in patients with chronic pain conditions. Curr Drug Ther. 2011;6(4):296–303.
Marchand S. Pharmacological and surgical approaches to pain control. In: Marchand S, editor. The phenomenon of pain. Seattle: IASP Press; 2012. p. 163–90.
Benoliel R, Sharav Y. Neuropathic orofacial pain. Compend Contin Educ Dent. 1998;19(11):1099–1102, 1104, passim; quiz 1116.
van Seventer R, Bach FW, Toth CC, et al. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. Eur J Neurol. 2010;17(8):1082–9.
Benoliel R, Eliav E. Neuropathic orofacial pain. Alpha Omegan. 2012;105(3–4):66–74.
Haribabu PK, Eliav E, Heir GM. Topical medications for the effective management of neuropathic orofacial pain. J Am Dent Assoc. 2013;144(6):612–4.
Heir G, Karolchek S, Kalladka M, et al. Use of topical medication in orofacial neuropathic pain: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(4):466–9.
Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446–52.
Pertes R, Cohen HV, Schwartz AH. UMDNJ-CDE: update in orofacial pain. An internet course. 2012. http://dentalschool.umdnj.edu/CDE/13-10-07_OFPnet.html
Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006;26(2):199–207.
Graff-Radford SB. Neurovascular pain. Alpha Omegan. 2012;105(3–4):86–91.
Graff-Radford S. Migraine prophylaxis. Clin Fam Pract. 2005;7(3):445–62.
Ramadan NM. Current trends in migraine prophylaxis. Headache. 2007;47(Suppl 1):S52–7.
Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia. 2008;28(6):585–97.
Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012;52(6):930–45.
Burstein R, Jakubowski M, Rauch SD. The science of migraine. J Vestib Res. 2011;21(6):305–14.
Lopez-Jornet P, Camacho-Alonso F, De la Mano-Espinosa T. Complementary and alternative medical therapies in patients with burning mouth syndrome. J Altern Complement Med. 2011;17(4):289–90.
Melchart D, Linde K, Fischer P, et al. Acupuncture for idiopathic headache (Cochrane review). Cochrane Libr. Vol Issue 2: Oxford: Update Software; 2003.
Myers CD, White BA, Heft MW. A review of complementary and alternative medicine use for treating chronic facial pain. J Am Dent Assoc. 2002;133(9):1189–1196; quiz 1259–1160.
Yan Z, Ding N, Hua H. A systematic review of acupuncture or acupoint injection for management of burning mouth syndrome. Quintessence Int. 2012;43(8):695–701.
Scardina GA, Ruggieri A, Provenzano F, Messina P. Burning mouth syndrome: Is acupuncture a therapeutic possibility? Br Dent J. 2010;209(1):E2.
Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 1991;44(3):293–9.
Arendt-Nielsen L, Petersen-Felix S. Wind-up and neuroplasticity: Is there a correlation to clinical pain? Eur J Anaesthesiol Suppl. 1995;10:1–7.
Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R. Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia. 2006;26(8):940–8.
George SZ, Wittmer VT, Fillingim RB, Robinson ME. Sex and pain-related psychological variables are associated with thermal pain sensitivity for patients with chronic low back pain. J Pain. 2007;8(1):2–10.
Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 2000;85(3):483–491.
Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 2001;91(1–2):165–75.
Tousignant-Laflamme Y, Page S, Goffaux P, Marchand S. An experimental model to measure excitatory and inhibitory pain mechanisms in humans. Brain Res. 2008;1230:73–9.
Craggs JG, Staud R, Robinson ME, Perlstein WM, Price DD. Effective connectivity among brain regions associated with slow temporal summation of C-fiber-evoked pain in fibromyalgia patients and healthy controls. J Pain. 2012;13(4):390–400.
Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain. 1998;76(1–2):71–81.
Raphael KG, Janal MN, Anathan S, Cook DB, Staud R. Temporal summation of heat pain in temporomandibular disorder patients. J Orofac Pain. 2009;23(1):54–64.
Sato H, Saisu H, Muraoka W, Nakagawa T, Svensson P, Wajima K. Lack of temporal summation but distinct after sensations to thermal stimulation in patients with combined tension-type headache and myofascial temporomandibular disorder. J Orofac Pain. 2012;26(4):288–95.
Juhl GI, Jensen TS, Norholt SE, Svensson P. Central sensitization phenomena after third molar surgery: a quantitative sensory testing study. Eur J Pain. 2008;12(1):116–27.
Cathcart S, Winefield AH, Lushington K, Rolan P. Noxious inhibition of temporal summation is impaired in chronic tension-type headache. Headache. 2010;50(3):403–12.
Eide PK, Rabben T. Trigeminal neuropathic pain: pathophysiological mechanisms examined by quantitative assessment of abnormal pain and sensory perception. Neurosurgery. 1998;43(5):1103–10.
Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–5.
Julien N, Goffaux P, Arsenault P, Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain. 2005;114(1–2):295–302.
Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain. 1997;70(1):41–51.
Maixner W, Fillingim R, Booker D, Sigurdsson A. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain. 1995;63(3):341–51.
Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain. 1991;46(2):125–32.
Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain. 2005;118(1–2):215–23.
Pud D, Granovsky Y, Yarnitsky D. The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans. Pain. 2009;144(1–2):16–9.
van Wijk G, Veldhuijzen DS. Perspective on diffuse noxious inhibitory controls as a model of endogenous pain modulation in clinical pain syndromes. J Pain. 2010;11(5):408–19.
Staud R. Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother. 2012;12(5):577–85.
Yarnitsky D, Crispel Y, Eisenberg E, et al. Prediction of chronic post-operative pain: pre-operative DNIC testing identifies patients at risk. Pain. 2008;138(1):22–8.
Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10(5):447–85.
Breslau N, Rasmussen BK. The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology. 2001;56(6 Suppl 1):S4–12.
Rasmussen BK. Epidemiology of headache. Cephalalgia. 1995;15(1):45–68.
List T, Leijon G, Helkimo M, Oster A, Dworkin SF, Svensson P. Clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study. J Orofac Pain. 2007;21(2):89–98.
Rauhala K, Oikarinen KS, Jarvelin MR, Raustia AM. Facial pain and temporomandibular disorders: an epidemiological study of the Northern Finland 1966 Birth Cohort. Cranio. 2000;18(1):40–6.
Ram S, Teruel A, Kumar SK, Clark G. Clinical characteristics and diagnosis of atypical odontalgia: implications for dentists. J Am Dent Assoc. 2009;140(2):223–8.
Lt Charleston. Burning mouth syndrome: a review of recent literature. Curr Pain Headache Rep. 2013;17(6):336.
Dao TTT. Pain and gender. In: Sessle B, Lavigne GJ, Lund JP, Dubner R, editors. Orofacial pain: From basic science to clinical management. 2nd ed. Hanover Park: Quintessence; 2008. p. 101–108.
Riley JL 3rd, Robinson ME, Wise EA, Myers CD, Fillingim RB. Sex differences in the perception of noxious experimental stimuli: a meta-analysis. Pain. 1998;74(2–3):181–7.
Sherman JJ, LeResche L, Mancl LA, Huggins K, Sage JC, Dworkin SF. Cyclic effects on experimental pain response in women with temporomandibular disorders. J Orofac Pain. 2005;19(2):133–43.
LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain. 2003;106(3):253–61.
Aloisi AM, Bonifazi M. Sex hormones, central nervous system and pain. Horm Behav. 2006;50(1):1–7.
Burns JW, Johnson BJ, Devine J, Mahoney N, Pawl R. Anger management style and the prediction of treatment outcome among male and female chronic pain patients. Behav Res Ther. 1998;36(11):1051–62.
Jensen IB, Bergstrom G, Ljungquist T, Bodin L, Nygren AL. A randomized controlled component analysis of a behavioral medicine rehabilitation program for chronic spinal pain: are the effects dependent on gender? Pain. 2001;91(1–2):65–78.
Granot M, Weissman-Fogel I, Crispel Y, et al. Determinants of endogenous analgesia magnitude in a diffuse noxious inhibitory control (DNIC) paradigm: Do conditioning stimulus painfulness, gender and personality variables matter? Pain. 2008;136(1–2):142–9.
Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611–5.
Fillingim RB, Maixner W, Kincaid S, Silva S. Sex differences in temporal summation but not sensory-discriminative processing of thermal pain. Pain. 1998;75(1):121–7.
Serrao M, Rossi P, Sandrini G, et al. Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain. 2004;112(3):353–60.
Staud R, Robinson ME, Vierck CJ Jr, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain. 2003;101(1–2):167–74.
Baad-Hansen L, Poulsen HF, Jensen HM, Svensson P. Lack of sex differences in modulation of experimental intraoral pain by diffuse noxious inhibitory controls (DNIC). Pain. 2005;116(3):359–65.
France CR, Suchowiecki S. A comparison of diffuse noxious inhibitory controls in men and women. Pain. 1999;81(1–2):77–84.
Marchand S. Differences between men an women in pain: more than a matter of perception. In: Marchand S, editor. The phenomenon of pain. Seattle: IASP Press; 2012. p. 271–294.
Dao T. Sex differences in pain. J Am Dent Assoc. 2012;143(7):764–5.
Straube S, Andrew Moore R, Derry S, McQuay HJ. Vitamin D and chronic pain. Pain. 2009;141(1–2):10–13.
Raphael KG, Marbach JJ, Touger-Decker R. Dietary fiber intake in patients with myofascial face pain. J Orofac Pain. 2002;16(1):39–47.
Ohrbach R, Larsson P, List T. The jaw functional limitation scale: development, reliability, and validity of 8-item and 20-item versions. J Orofac Pain. 2008;22(3):219–30.
Irving J, Wood GD, Hackett AF. Does temporomandibular disorder pain dysfunction syndrome affect dietary intake? Dent Update. 1999;26(9):405–7.
Durham J, Steele JG, Wassell RW, et al. Creating a patient-based condition-specific outcome measure for temporomandibular disorders (TMDs): oral health impact profile for TMDs (OHIP-TMDs). J Oral Rehabil. 2011;38(12):871–83.
Kharti R, Kallanka M, Viswanath A, et al. Nutrional screening of patients with orofacial pain disorders. Paper presented at: International Association of Dental Research. 2007; New Orleans.
Aggarwal VR, Lunt M, Zakrzewska JM, Macfarlane GJ, Macfarlane TV. Development and validation of the Manchester orofacial pain disability scale. Community Dent Oral Epidemiol. 2005;33(2):141–9.
Kurita H, Ohtsuka A, Kurashina K, Kopp S. Chewing ability as a parameter for evaluating the disability of patients with temporomandibular disorders. J Oral Rehabil. 2001;28(5):463–5.
Bell RF, Borzan J, Kalso E, Simonnet G. Food, pain, and drugs: does it matter what pain patients eat? Pain. 2012;153(10):1993–6.
Wober C, Wober-Bingol C. Triggers of migraine and tension-type headache. Handbook of clinical neurology headache. vol 972010:161–172.
Holick M, Vitamin D. status: Measurement, interpretation and clinical application. Ann Epidemiol. 2009;19(2):73–8.
Turner MK, Hooten WM, Schmidt JE, Kerkvliet JL, Townsend CO, Bruce BK. Prevalence and clinical correlates of vitamin D inadequacy among patients with chronic pain. Pain Med. 2008;9(8):979–84.
Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain. 2007;129(1–2):210–23.
Sardella A, Lodi G, Demarosi F, Uglietti D, Carrassi A. Causative or precipitating aspects of burning mouth syndrome: a case-control study. J Oral Pathol Med. 2006;35(8):466–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nasri-Heir, C., Benoliel, R., Touger-Decker, R., Epstein, J.B., Eliav, E. (2014). Orofacial Pain. In: Touger-Decker, R., Mobley, C., Epstein, J. (eds) Nutrition and Oral Medicine. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-490-6_17
Download citation
DOI: https://doi.org/10.1007/978-1-60761-490-6_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-60761-489-0
Online ISBN: 978-1-60761-490-6
eBook Packages: MedicineMedicine (R0)